President Moon Jae-in visited the SK Bioscience factory in Andong-si, Gyeongbuk, on the 20th to inspect the COVID-19 vaccine production site. January 20, 2021<br>Photo by Yonhap News

President Moon Jae-in visited the SK Bioscience factory in Andong-si, Gyeongbuk, on the 20th to inspect the COVID-19 vaccine production site. January 20, 2021
Photo by Yonhap News

View original image


[Asia Economy Reporter Park Hyesook] Incheon City will operate a separate organization to ensure the smooth administration of COVID-19 vaccines.


On the 29th, the city announced that it will launch the "COVID-19 Vaccine Administration Promotion and Support Team," consisting of 26 members across 5 teams, led by the Deputy Mayor for Administration as the overall head of the task force.


The Vaccination Promotion Team will be led by the Director of the Health and Sports Bureau and will coordinate with the Korea Disease Control and Prevention Agency, while the Vaccination Support Team will be led by the Director of the Citizen Safety Headquarters and the Director of the Administration Bureau, working in cooperation with the Ministry of the Interior and Safety.


Additionally, to respond quickly to adverse reactions and conduct epidemiological investigations, a private advisory committee composed of medical specialists will be operated, along with a regional consultative body consisting of the Medical Association, Nursing Association, Police, and Fire Department.


Each district and county will also operate a promotion and support team led by the deputy head of the local government and composed of working-level members.


Vaccination institutions will be selected based on platforms such as mRNA (nucleic acid) vaccines and viral vector vaccines.


For mRNA (nucleic acid) vaccines, which require ultra-low temperature freezers, one vaccination center will be secured in each of the 10 districts and counties, with two centers established in Seo-gu and Namdong-gu, which have populations exceeding 500,000.


For viral vector vaccines, approximately 500 existing designated medical institutions that meet the criteria will be selected.


The city plans for medical institution workers and military personnel to receive vaccinations within their respective institutions, and is also considering home visits by public health centers for residents of group facilities such as nursing homes and long-term care hospitals who have mobility difficulties.



The COVID-19 vaccination target population in Incheon City is 2.47 million people aged 18 and over, out of a total population of 2.94 million (83.9%).


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing